+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Macular Degeneration"

From
Retinal Biologics Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Retinal Biologics Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Ophthalmic Laser Market - Foreasts from 2021 to 2026 - Product Thumbnail Image

Ophthalmic Laser Market - Foreasts from 2021 to 2026

  • Report
  • January 2022
  • 115 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Fundus Cameras Market by Product, by End-User, and By Region - Product Thumbnail Image

Fundus Cameras Market by Product, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Ophthalmic Microscopes Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Ophthalmic Microscopes Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness. Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD. Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more